For
the six months ended June 30, 2026 and 2025, the calculations of basic and diluted loss per share are the same because potential dilutive
securities would have had an antidilutive effect. The potentially dilutive securities consisted of the following:
Schedule of Potentially Dilutive Securities
| | |
June
30,
2026 | | |
June
30,
2025 | |
| Warrants | |
| 2,910,991 | | |
| 91,549 | |
| Options | |
| 24,966 | | |
| 54,034 | |
| Common
stock equivalent of Series A Convertible Preferred stock | |
| 125 | | |
| 125 | |
| Total | |
| 2,936,082 | | |
| 145,708 | |
| Anti-dilutive Securities | |
| 2,936,082 | | |
| 145,708 | |
|